Antidysrhythmic Meds Flashcards
Why cardiac dysrhythmias occur
Automaticity:
Decreased = S Brady
Increased = S Tachy
Conductivity:
A block or delay
Antidysrhythmics uses depend on what?
Is this a new pattern for pt
Dysrhythmias harmful
Prelife threatening rhythm
rhythm may lead to future problems
Antidysrhythmics expected outcome
Resolve dysrhythmia
Restore:
CO
HR
BP
Cap refill
Return to normal state of being
Antidysrhythmics types
Group 1: sodium channel blockers
*1A,1B,1C
Group II: beta blockers
Group III: potassium channel blockers
Group IV: caclium chennel blockers
Unclassified group
Antidysrhythmics
Na channel blockers
Group 1A
Reduce exitability of heart
Encourage reperfusion
Delay repolarization in atria, ventricles and purkinje fibers
Antidysrhythmics
Na channel blcokers
1A
Med
Widening QRS (good but not too much)
Show that excitability is slowing down
For ventricular issue
Med: procainamide
Antidysrhythmics
Na channel blockers
1A
Nursing management
Dont utilize with existing conduction delay issue (blocks)
Dont give to myasthenia gravis pt
*(may increase muscle weakness)
Watch for toxic effects:
Widening of the QRS >25%
Abolition of the Pwave
Hold or stop administation notify provider
Antidysrhythmics
Na channel blockers
Group 1B
Decrease depolarization, automaticity, excitability
Main effect in ventricles
Tx: PVCs premature ventricular contractions
Antidysrhythmics
Na channel blockers
1B
Lidocaine
Antidysrhythmics
Na channel blockers
1B
Dont use with
Monitor
Stop if
Do not use with cardiac blocks
Check blood level for toxicity
Constant ECG monitoring for IV admin
Stop infusion if toxic signs:
Prolonged PR interval or QRS complex
Aggravation of existing dysrhythmia
Antidysrhythmics
Na channel blockers
Group 1C
Prevent supraventricular tachydyrhythmias
Med: aminodarone
Group II meds
Beta blockers
Lower HR and BP
Group III
Potassium channel blockers
Prolong the effective refractory period
Chance for heart to rest
Prevent reentry phenomenon:
***HR shoots up after getting a good rhythm
Group III
Potassium channel blockers meds
Aminodarone
Group IV
Calcium channel blockers
Vasodilation